Abstract
Purpose: To evaluate survival rates and side effects after stereotactically-guided radiotherapy (SRT) in patients with recurrent medulloblastoma of the brain.
Methods and materials: Between 1992 and 2000, 20 patients with 29 radiological manifestations were treated with fractionated SRT (n=21) or radiosurgery (n=8). Median age was 16 years with 6 patients ≤14 years. All patients had prior cranio-spinal radiotherapy plus boost to the posterior fossa with a total dose of 54 Gy. Time to recurrence was 33 months mean. Eighteen of the 29 lesions were located within the boost volume. Chemotherapy was given according to current international study protocols (HIT) in all patients. Mean total dose for re-irradiation was 24 Gy for fractionated stereotactically-guided radiotherapy, and 15 Gy for radiosurgery. Mean follow-up was 88.5 months.
Results: Overall local control was 89.7%. Thirteen recurrences showed partial or complete response in CT/MR-imaging, 13 showed stable disease. Local tumor progression was seen 5 months mean after radiotherapy in three cases. A multifocal intracranial progression was seen in 9 patients, 5 patients developed additional spinal metastases. Thirteen patients died with disseminated cranio-spinal progression, after 72.6 months median. No late toxicity >CTC II∘ especially no brain radionecrosis was seen after radiotherapy.
Conclusion: SRT is effective and safe in the treatment of recurrent medulloblastoma to improve local control without evident side effects. The main problem remains the control of subclinical cranio-spinal dissemination.
Similar content being viewed by others
References
Bloom HJG, Wallace ENK, Henk JM: The treatment and prognosis of medulloblastoma in children: a study of 82 verified cases. Am J Roentgenol 105: 43-62, 1969
Kortmann R-D, Kühl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavic I, Wolff J, Meisner C, Wiestler O, Sörensen N, Warmuth-Metz M, Bamberg M: Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT'91. Int J Radiat Oncol Biol Phys 46: 269-279, 2000
Deutsch M, Thomas PR, Krischer J, Boyett JM, Albright L, Aronin P, Langston J, Allen JC, Packer RJ, Linggood R, Mulhern R, Stanley P, Stehbens JA, Duffner P, Kun L, Rorke L, Cherlow J, Freidman H, Finlay JL, Vietti T: Results of a prospective randomised trial comparing standard dose neuroaxis irradiation (3,600 cGy/20) with reduced neuroaxis irradiation (2,300 cGy/13) in patients with low stage medulloblastoma. Pediatr Neurosurg 24: 167-177, 1996
Khafaga Y, Kandil AE, Jamshed A, Hassounah M, DeVol E, Gray AJ: Treatment results for 149 medulloblastoma patients from one institution. Int J Radiat Oncol Biol Phys 35: 501-506, 1996
Berry MP, Jenkin RD, Keen CW, Nair BD, Simpson WJ: Radiation treatment of medulloblastoma. A 21 year review. J Neurosurg 55: 43-51, 1981
Jenkin RD: Medulloblastoma in childhood: radiation therapy. Can Med Assoc J 100: 1-3, 1969
Tarbell NJ, Loeffler JS, Silver B, Lynch E, Lavally BL, Kupsky WJ, Scott M, Sallan SE: The change in patterns of relapse in medulloblastoma. Cancer 68: 1600-1604, 1991
Merchant TE, Wang M-H, Haida T, Lindsley KL, Finlay J, Dunkel IJ, Rosenblum MK, Leibel SA: Medulloblastoma: long term results for patients treated with definitive radiation therapy during the computed tomography era. Int J Radiat Oncol Biol Phys 36: 29-35, 1996
Prados MD: Treatment strategies for patients with recurrent brain tumors. Radiat Oncol 1: 62-68, 1991
Kramer S: Radiation therapy in the management of brain tumors in children. Annals NY Acad Sci 159: 571-584, 1969
Marks JE, Baglan RJ, Prassad SC, Blank WF: Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 7: 243-252, 1981
Debus J, Engenhart-Cabillic R, Knopp MV, Schad LR, Schlegel W, Wannenmacher M: Bildorientierte Planung minimalinvasiver konformierender Bestrahlungsverfahren im Kopf-Hals-Bereich. Radiologe 36: 732-736, 1996
Debus J, Engenhart-Cabillic R, Holz FG, Pastyr O, Rhein B, Bortfeld T, Wannenmacher M: Stereotactic precision radiotherapy in the treatment of intraocular malignancy with a micro-multileaf collimator. Front Radiat Ther Oncol 30: 39-46, 1997
Höss A, Debus J, Bendl R, Engenhart-Cabillic R, Schlegel W: Computerverfahren in der dreidimensionalen Strahlentherapieplanung. Radiologe 35: 583-586, 1995
Schlegel W, Pastyr O, Bortfeld T, Gademann G, Menke M, Maier-Borst W: Computer systems and mechanical tools for stereotactically guided conformation therapy with linear accelerators. Int J Radiat Oncol Biol Phys 24: 781-787, 1992
Paulino AC, Narayana A, Mohideen MN, Jeswani S: Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. Int J Radiat Oncol Biol Phys 46: 281-286, 2000
Bauman GS, Sneed PK, Wara WM, Stalpers LJA, Chang SM, McDermott MW, Gutin PH, Larson DA: Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 36: 433-441, 1996
Fukunaga-Johnson N, Lee JH, Sandler HM, Robertson P, McNeil E, Goldwein JW: Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa? Int J Radiat Oncol Biol Phys 42: 143-146, 1998
Tait DM, Thornton-Jones H, Bloom HJ, Lemerle J, Morris-Jones P: Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial International Society of Pediatric Oncology (SIOP). Eur J Cancer 26: 464-469, 1990
Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, Phillips A, Neidhardt MK: Prospective randomized trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Pediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25: 166-178, 1995
Saran FH, Drievers PH, Thilmann C, Mose S, Wilson P, Sharpe G, Adamietz TA, Böttcher HD: Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation. Int J Radiat Oncol Biol Phys 42: 959-967, 1998
Burger PC, Mahaley MS, Dudka L, Vogel FS: The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases. Cancer 44: 1256-1272, 1979
Packer RJ, Zimmermann RA, Bilaniuk LT: Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer 58: 635-640, 1986
Schultheiss TE, Kun LE, Ang KK, Stephens LC: Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31: 1093-1112, 1995
Tokuuye K, Akine Y, Sumi M, Kagami K, Ikeda H, Oyama H, Inou Y, Shibui S, Nomura K: Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 40: 1151-1155, 1998
Shepherd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, Brada M: Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 37: 393-398, 1997
Grill J, Renaux VK, Bulteau C, Viguier D, Levy-Piebois C, Sainte-Rose C, Dellatolas G, Raquin M-A, Jambaque I, Kalifa C: Long-term interectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45: 137-145, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Milker-Zabel, S., Zabel, A., Thilmann, C. et al. Results of Three-dimensional Stereotactically-guided Radiotherapy in Recurrent Medulloblastoma. J Neurooncol 60, 227–233 (2002). https://doi.org/10.1023/A:1021184400053
Issue Date:
DOI: https://doi.org/10.1023/A:1021184400053